AI may Help Clinicians Personalize Treatment for Generalized Anxiety Disorder

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI) models may help clinicians identify factors to predict long-term recovery and better personalize patient treatment, according to researchers from Penn State.

The researchers used a form of AI called machine learning to analyze more than 80 baseline factors - ranging from psychological and sociodemographic to health and lifestyle variables - for 126 anonymized individuals diagnosed with GAD. The data came from the U.S. National Institutes of Health’s longitudinal study called Midlife in the United States, which samples health data from continental U.S. residents aged 25 to 74 who were first interviewed in 1995-96. The machine learning models identified 11 variables that appear most important for predicting recovery and nonrecovery, with up to 72% accuracy, at the end of a nine-year period. The researchers published their findings in the March issue of the Journal of Anxiety Disorders.

"Prior research has shown a very high relapse rate in GAD, and there’s also limited accuracy in clinician judgment in predicting long-term outcomes," said Candice Basterfield, lead study author and doctoral candidate at Penn State. "This research suggests that machine learning models show good accuracy, sensitivity and specificity in predicting who will and won’t recover from GAD. These predictors of recovery could be really important for helping to create evidence-based, personalized treatments for long-term recovery."

The researchers ran the baseline variables through two machine learning models: a linear regression model that examines the relationship between two variables and plots data points along a nearly straight line, and a nonlinear model that branches out like a tree, splitting and adding new trees and plotting how it self-corrects prior errors. The models identified the 11 variables key to predicting recovery or nonrecovery over the nine-year period, with the linear model outperforming the nonlinear model. The models also identified how important each variable was compared to the others for predicting recovery outcomes.

The researchers found that higher education level, older age, more friend support, higher waist-to-hip-ratio and higher positive affect, or feeling more cheerful, were most important to recovery, in that order. Meanwhile, depressed affect, daily discrimination, greater number of sessions with a mental health professional in the past 12 months and greater number of visits to medical doctors in the past 12 months proved most important to predicting nonrecovery. The researchers validated the model findings by comparing the machine learning predictions to the MIDUS data, finding that the predicted recovery variables tracked with the 95 participants who showed no GAD symptoms at the end of the nine-year period.

The findings suggest that clinicians can use AI to identify these variables and personalize treatment for GAD patients - especially those with compounding diagnoses, according to the researchers.

Nearly 50% to 60% of people with GAD have comorbid depression, said Michelle Newman, senior author and professor of psychology at Penn State. She explained that personalized treatments could target that depression as well as treat anxiety.

"Machine learning not only looks at the individual predictors but helps us understand both the weight of those predictors - how important they are to recovery or nonrecovery - and the way those predictors interact with one another, which is beyond anything a human might be able to predict," Newman said.

The researchers noted that the study could not determine the duration of GAD over the nine-year period, as it’s a chronic condition and periods where symptoms manifest strongly come and go. The work, however, lays the groundwork for more tailored treatments, they said.

"This work helps us begin to understand more ways in which treatment could be personalized for specific individuals," Newman said.

The U.S. National Institutes of Health, through the National Institute of Mental Health, supported this research.

Basterfield C, Newman MG.
Development of a machine learning-based multivariable prediction model for the naturalistic course of generalized anxiety disorder.
J Anxiety Disord. 2025 Mar;110:102978. doi: 10.1016/j.janxdis.2025.102978

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...